Narcan, the naloxone nasal spray used to reverse opioid overdose, was just FDA-approved for over-the-counter sale—a major victory for harm reduction advocates and public health.
Substance Use Disorder
Addressing the disease that affects brain and behavior, leading to an inability to control the use of drugs or medication
Substance Use Disorder Headlines
Explore the latest public health research and insights about substance use disorder.
Substance Use Disorder Faculty Experts
Looking for prominent public health experts in the field of substance use disorder? They’re here at the Bloomberg School of Public Health.
G. Caleb Alexander, MD, MS, is a practicing internist and epidemiologist focused on maximizing the use, safety, and effectiveness of prescription medicines.
Susan Sherman, PhD '00, MPH, brings harm reduction evidence to inform drug policy and programming in order to reduce overdose deaths and other harms to people who use drugs.
Sean Allen, DrPH, MPH, uses research to inform drug policies and eliminate health disparities among people who inject drugs.
Elizabeth Stuart, PhD, uses statistical methods to help learn about the effects of public health programs and policies, often with a focus on mental health and substance use.
Haneefa Tasleem Saleem, PhD ’14, MPH, ’09, conducts research to inform and evaluate approaches aimed at improving HIV prevention and treatment and other health outcomes for people who use drugs globally.
Melissa Walls, PhD, MA, is an Indigenous researcher who works with American Indian and First Nations communities to promote health equity through culturally centered projects.